Arkolith/Insider Trading/TEVA/Form 4

Savage Brian

Interim Chief Legal OfficerTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$87K
Net Open-Market Flow
-$87K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)1K$32.46$38K8K
Mar 4, 2026Option exercise(M)5K——8K
Mar 4, 2026Sell(S)1K$32.46$48K6K
Mar 4, 2026Option exercise(M)3K——10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)4K—$08K
Mar 4, 2026Option exercise(M)5K—$00
Mar 4, 2026Grant(A)11K—$011K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-096477) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML